Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

2.70
Delayed Data
As of Dec 02
 +0.15 / +5.88%
Today’s Change
2.50
Today|||52-Week Range
6.93
-50.00%
Year-to-Date

Today’s Trading

Previous close2.55
Today’s open2.55
Day’s range2.55 - 2.89
Volume478,533
Average volume (3 months)266,562
Market cap$82.7M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-27.30%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book1.65

Competitors

 Today’s
change
Today’s
% change
CPHRCipher Pharmaceutica...-0.14-4.70%
CDNACareDx Inc-0.25-7.35%
PMDPsychemedics Corp-0.68-2.90%
ONCSOncoSec Medical Inc+0.01+0.78%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Bill Welch
Vice President-Finance &
Administration
Elizabeth Anderson
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs